ReviewJournal of cosmetic dermatology2019
The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): A consensus on practical guidance.
Review in Journal of cosmetic dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Administration Method and Potential Efficacy of Hyaluronidase for Hyaluronic Acid Filler-Related Vision Loss: A Systematic Review.Aesthetic plastic surgery · 2024Pooled it
- EYE-CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra-Arterial Injection of Soft-Tissue Fillers: 2025 Update.Journal of cosmetic dermatology · 2025Article
- Management of vision loss associated with complications of cosmetic filler injections.Frontiers in ophthalmology · 2025Review
- Public Awareness of Blindness Caused by Hyaluronic Acid Injection in China: A Questionnaire Survey.Plastic and reconstructive surgery. Global open · 2024Article
- Phthisical eye and orbital ischemia after cosmetic platelet-rich plasma injection to the forehead.American journal of ophthalmology case reports · 2024Article
- Use of platelet rich plasma for skin rejuvenation.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024Review
- Disastrous cerebral and ocular vascular complications after cosmetic facial filler injections: a retrospective case series study.Scientific reports · 2024Article
- Clinical Manifestations and Prognosis of Embolism Caused by Filler Injection in Different Facial Regions.Plastic and reconstructive surgery. Global open · 2023Article
- Ophthalmic Complications of Periorbital and Facial Aesthetic Procedures: A Literature Review.Cureus · 2023Review
- Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions.Molecules (Basel, Switzerland) · 2022Review
- Sudden vision loss and neurological deficits after facial hyaluronic acid filler injection.Neurological research and practice · 2022Article
- Distal Internal Maxillary Artery Occlusion with Palatal Necrosis following Cheek Injection with Calcium Hydroxylapatite.Plastic and reconstructive surgery. Global open · 2022Article
- Consensus Opinion for The Management of Soft Tissue Filler Induced Vision Loss.The Journal of clinical and aesthetic dermatology · 2021Review
- An Efficacy and Safety Study of Intra-arterial Recanalization of Occluded Ophthalmic Arteries in Patients with Monocular Blindness Caused by Injection of Hyaluronic Acid in Facial Tissues.Aesthetic plastic surgery · 2021Article
- The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments.Clinical, cosmetic and investigational dermatology · 2021Article
- Treatment Algorithm for Hyaluronic Acid-Related Complication Based on a Systematic Review of Case Reports, Case Series, and Clinical Experience.Craniomaxillofacial trauma & reconstruction · 2020Review
- A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management.Aesthetic surgery journal · 2020Article
- Visual Loss after Platelet-rich Plasma Injection into the Face.Neuro-ophthalmology (Aeolus Press) · 2020Article
- Soft-tissue Filler-associated Blindness: A Systematic Review of Case Reports and Case Series.Plastic and reconstructive surgery. Global open · 2019Article
- The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): A consensus on practical guidance.Journal of cosmetic dermatology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVisual loss (blindness) caused by injection of soft tissue fillers is a rare but devastating issue to both patient and practitioner. There is a lack of any structured protocol in the management of this problem
aimsTo produce a pathway for the management of hyaluronic acid aesthetic interventional induced visual loss that was based on the current available literature and guidelines. evidence proposed guidance for the practical management of this problem. was evaluated and a pathway has been developed for patient management and specialist advice
methodA consensus group experts involved in aesthetic intervention, visual loss research and with experience in dealing with visual loss assessed the current literature and proposed guidelines available. Using the protocols available a pathway for the treatment of aesthetic interventional induced visual loss was proposed.
resultsThe group produce a set of guidelines for the practitioner to use as an emergency situation and for use in a delayed presentation. The group also produced guidelines for specialists to use in a secondary care setting.
conclusionsThese recommendations are based on current publications and or consensus view as there is still a lack of robust Level I data to support any particular intervention therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.